These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23932516)

  • 1. Bacterial cell division as a target for new antibiotics.
    Sass P; Brötz-Oesterhelt H
    Curr Opin Microbiol; 2013 Oct; 16(5):522-30. PubMed ID: 23932516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell division protein FtsZ: from structure and mechanism to antibiotic target.
    Silber N; Matos de Opitz CL; Mayer C; Sass P
    Future Microbiol; 2020 Jun; 15():801-831. PubMed ID: 32692252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
    Li X; Ma S
    Eur J Med Chem; 2015 May; 95():1-15. PubMed ID: 25791674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the assembly of bacterial cell division protein FtsZ with small molecules.
    Schaffner-Barbero C; Martín-Fontecha M; Chacón P; Andreu JM
    ACS Chem Biol; 2012 Feb; 7(2):269-77. PubMed ID: 22047077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic inhibitors of bacterial cell division targeting the GTP-binding site of FtsZ.
    Ruiz-Avila LB; Huecas S; Artola M; Vergoñós A; Ramírez-Aportela E; Cercenado E; Barasoain I; Vázquez-Villa H; Martín-Fontecha M; Chacón P; López-Rodríguez ML; Andreu JM
    ACS Chem Biol; 2013 Sep; 8(9):2072-83. PubMed ID: 23855511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
    Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
    Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of FtsZ inhibition: a patent perspective.
    Awasthi D; Kumar K; Ojima I
    Expert Opin Ther Pat; 2011 May; 21(5):657-79. PubMed ID: 21413908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
    Haranahalli K; Tong S; Ojima I
    Bioorg Med Chem; 2016 Dec; 24(24):6354-6369. PubMed ID: 27189886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of agents targeting FtsZ assembly.
    Panda D; Bhattacharya D; Gao QH; Oza PM; Lin HY; Hawkins B; Hibbs DE; Groundwater PW
    Future Med Chem; 2016 Jun; 8(10):1111-32. PubMed ID: 27284850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target.
    Ur Rahman M; Wang P; Wang N; Chen Y
    Bosn J Basic Med Sci; 2020 Aug; 20(3):310-318. PubMed ID: 32020845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FtsZ as an Antibacterial Target: Status and Guidelines for Progressing This Avenue.
    Kusuma KD; Payne M; Ung AT; Bottomley AL; Harry EJ
    ACS Infect Dis; 2019 Aug; 5(8):1279-1294. PubMed ID: 31268666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FtsZ inhibition: a promising approach for antistaphylococcal therapy.
    Singh P; Panda D
    Drug News Perspect; 2010 Jun; 23(5):295-304. PubMed ID: 20603653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs.
    Beuria TK; Singh P; Surolia A; Panda D
    Biochem J; 2009 Sep; 423(1):61-9. PubMed ID: 19583568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
    Haydon DJ; Stokes NR; Ure R; Galbraith G; Bennett JM; Brown DR; Baker PJ; Barynin VV; Rice DW; Sedelnikova SE; Heal JR; Sheridan JM; Aiwale ST; Chauhan PK; Srivastava A; Taneja A; Collins I; Errington J; Czaplewski LG
    Science; 2008 Sep; 321(5896):1673-5. PubMed ID: 18801997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FtsZ for antibacterial therapy: a promising avenue.
    Kapoor S; Panda D
    Expert Opin Ther Targets; 2009 Sep; 13(9):1037-51. PubMed ID: 19659446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial cell division proteins as antibiotic targets.
    den Blaauwen T; Andreu JM; Monasterio O
    Bioorg Chem; 2014 Aug; 55():27-38. PubMed ID: 24755375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress of bacterial FtsZ inhibitors with a focus on peptides.
    Han H; Wang Z; Li T; Teng D; Mao R; Hao Y; Yang N; Wang X; Wang J
    FEBS J; 2021 Feb; 288(4):1091-1106. PubMed ID: 32681661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel compound with potential of an antibacterial drug targets FtsZ protein.
    Dasgupta D
    Biochem J; 2009 Sep; 423(1):e1-3. PubMed ID: 19740076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FtsZ inhibitors as a new genera of antibacterial agents.
    Tripathy S; Sahu SK
    Bioorg Chem; 2019 Oct; 91():103169. PubMed ID: 31398602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of FtsZ inhibitors as potential antibacterial agents.
    Ma S; Ma S
    ChemMedChem; 2012 Jul; 7(7):1161-72. PubMed ID: 22639193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.